PHB1 and vitiligo: It could, therefore, be hypothesized that a reduced interaction of prohibitins with the tri-protein complex mentioned above, e.g., due to a decreased expression of prohibitins or to alterations in the binding sites, could be involved in the pathogenesis or clinical manifestations of vitiligo [79].